Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Yasunobu Kanamori"'
Autor:
Shingo Miyamoto, Daisuke Miyahara, Yasunobu Kanamori, Fusanori Yotsumoto, Kenichi Yoshikawa, Sung Ouk Nam, Noriko Nishimura, Tomohiro Ito
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 37:7-13
Autor:
Masako Sarugami, Satoru Tsukihara, Yohei Nagaya, Daiken Osaku, Fuminori Taniguchi, Tasuku Harada, Hiroaki Komatsu, Keisuke Miyamoto, Yasunobu Kanamori
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 35:509-514
Pregnancy increases the risk of venous thromboembolism (VTE). During pregnancy and a post-cesarean section, an increase in D-dimer levels can be observed. However, to date, the usefulness of the D-dimer level measurement for thrombosis in pregnant wo
Autor:
Yohei Nagaya, Hiroaki Komatsu, Tasuku Harada, Masako Sarugami, Yasunobu Kanamori, Hiroki Nagata, Satoru Tsukihara
Publikováno v:
Nagata H, Komatsu H, Nagaya Y, Tsukihara S, Sarugami M, Harada T, et al. Comparison of Total Laparoscopic Hysterectomy with Abdominal Total Hysterectomy in Patients with Benign Disease: A Retrospective Cohort Study. Yonago Acta Medica. 2019;62:273-277.
Background: The present study aimed to determine whether total laparoscopic hysterectomy (TLH) is being implemented safely and appropriately compared with abdominal total hysterectomy (ATH) in our hospital. Methods: We retrospectively reviewed clinic
Autor:
Yasunobu Kanamori, Noriko Nishimura, Takaya Nakaso, Tasuku Harada, Satoru Tsukihara, Hiroaki Komatsu, Takashi Harada, Fuminori Taniguchi, Masako Sarugami
Publikováno v:
Hiroaki Komatsu, Fuminori Taniguchi, Takashi Harada, Takaya Nakaso, Noriko Nishimura, Satoru Tsukihara, Masako Sarugami, Tasuku Harada, Yasunobu Kanamori, Re-evaluation of Urinary Trypsin Inhibitor on Pregnancy Course in Patients with Threatened Preterm D
Background We evaluated the necessity of urinary trypsin inhibitor for patients with threatened premature labor. Methods We enrolled 146 women with singleton pregnancies who were treated for threatened premature labor as inpatients. The uterine cervi
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 34:199-203
Autor:
Toyofumi Hirakawa, Yasunobu Kanamori, Fusanori Yotsumoto, Masamitsu Kurakazu, Tomohiro Ito, Shingo Miyamoto, Kenichi Yoshikawa, Kohei Miyata, Koichiro Shigekawa, Sung Ouk Nam, Satoshi Amada, Daisuke Miyahara
Publikováno v:
Anticancer research. 39(8)
Background/aim Initial treatment of endometrial cancer with surgery and platinum and taxane-based chemotherapy is often successful, but it remains unclear as to whether certain types of the disease relapse. The aim of this study was to identify the c
Autor:
Tetsuro Oishi, Shinya Sato, Satoru Tsukihara, Fuminori Taniguchi, Tasuku Harada, Yasunobu Kanamori, Masako Sarugami, Hiroaki Komatsu
Publikováno v:
Hiroaki Komatsu, Satoru Tsukihara, Shinya Sato, Masako Sarugami, Tetsuro Oishi, Fuminori Taniguchi, Tasuku Harada, Yasunobu Kanamori, Training in the Departments of Urology and Surgery for Gynecologists in Japan, Yonago Acta Medica, 2019, Volume 62, Issue
Background The authors wanted to understand the current situation concerning Japanese obstetricians' and gynecologists' ideas for and against training in other departments. Methods We sent questionnaires to obstetrics and gynecology (Ob-Gyn) speciali
Autor:
Satoru Tsukihara, Fuminori Taniguchi, Hiroki Nagata, Yasunobu Kanamori, Yohei Nagaya, Takaya Nakaso, Masako Sarugami, Tasuku Harada, Hiroaki Komatsu
Publikováno v:
Laparoscopic Surgery. 3:23-23
Background: Hysterectomy is commonly performed for uterine myomas, uterine cancers, and uterine prolapses. In this study, we aimed to evaluate the procedures for improving our surgical skill in total laparoscopic hysterectomy (TLH). Methods: Retrospe
Autor:
Hiroki Nagata, Hiroaki Komatsu, Yohei Nagaya, Satoru Tsukihara, Masako Sarugami, Tasuku Harada, Yasunobu Kanamori
Publikováno v:
Yonago Acta Medica; 2019, Vol. 62 Issue 4, p273-277, 5p
Autor:
Eiji Nanba, Kaori Adachi, Tadashi Igishi, Naoto Burioka, Eiji Shimizu, Miyako Takata, Naomi Miyake, Hiroki Chikumi, Yasunobu Kanamori, Akira Yamasaki
Publikováno v:
Cancer Biology & Therapy. 13:369-378
Epidermal growth factor receptor (EGFR) mutation is the best marker of sensitivity to the EGFR tyrosine kinase inhibitor gefitinib, but a marker for the anti-EGFR antibody cetuximab has not been identified in lung cancer. The present study investigat